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OBJECTIVE—The current study examines the prevalence of binge eating and its association
with adiposity and psychosocial functioning in a large, diverse sample of youth with type 2
diabetes.
RESEARCH DESIGN AND METHODS—In the TODAY study, 678 (mean age 14.0
years; 64.9% girls) of the 704 youth randomized to the study completed a self-report measure
ofeatingdisordersymptomsandwerecategorizedasnonovereaters,overeaters,subclinicalbinge
eaters, or clinical binge eaters.
RESULTS—Youth with clinical (6%) and subclinical (20%) levels of binge eating had signif-
icantly higher levels and rates of extreme obesity, global eating disorder and depressive symp-
toms, and impaired quality of life.
CONCLUSIONS—These ﬁndings highlight the importance of evaluating youth with type 2
diabetes for the presence of binge eating. Future research is needed to determine the cumulative
effects of disordered eating, obesity, and psychosocial distress on adherence to lifestyle change
recommendations and longitudinal response to treatment.
Diabetes Care 34:858–860, 2011
B
inge eating and other eating distur-
bances occur more commonly in
girls with type 1 diabetes than girls
without diabetes (1–3). However, dis-
turbed eating behaviors, such as binge
eating, have not been well studied in
youth with type 2 diabetes, despite risk
due to age and weight status (4,5). This
report summarizes binge eating and re-
lated psychosocial disturbances in a large
sample of youth with type 2 diabetes in
TODAY (Treatment Options for type 2
Diabetes in Adolescents and Youth).
RESEARCH DESIGN AND
METHODS—TODAY is a multicenter
randomized clinical trial funded by the
National Institute of Diabetes and Diges-
tive and Kidney Diseases (NIDDK) of the
National Institutes of Health (NIH). The
collaborative study includes 15 clinical
centers and a data coordinating center
(see Supplementary Data). The study de-
sign and objectives have been described
elsewhere(6).Theprotocolwasapproved
by an External Evaluation Committee
convened by the NIDDK and by Institu-
tional Review Boardsateachparticipating
institution. All participants provided
informed consent, and minor children
conﬁrmed assent according to local
guidelines. Enrollment began May 2004
and ended February 2009 with a total of
704 participants. Eligibility requirements
included 10–17 years of age, type 2 dia-
betes,2years’duration,BMI$85thper-
centileatdiagnosis,andanadultcaregiver
willing to support study participation. All
participants completed a run-in period to
discontinue nonstudy diabetes treat-
ments, achieve hemoglobin A1c (HbA1c)
,8% on metformin only, and demon-
strate adherence to the study protocol.
Demographic variables included age,
sex,self-reportrace/ethnicity,andhighest
household educational level as a proxy
for socioeconomic status. Baseline body
composition measures included height,
weight, waist circumference, and abdom-
inal height. BMI percentile, BMI z score,
and percent overweight were calculated.
Other physical health measures included
HbA1c, blood lipids, and blood pressure.
Of 704 randomized youth, 678 com-
pleted the baseline Youth Eating Disorder
Examination Questionnaire (YEDEQ), a
self-report measure of eating disorder
symptoms (7). Responses to “How many
times [over the past 28 days] have you
eaten what other people would think
was a really big amount of food, given
the situation?” (objective overeating epi-
sodes) and “On how many of these times
did you feel like you had lost control
while eating?” were used to derive eating
categories. Positive responses to both
questions were used to establish binge
eating, i.e., reporting episodes of objec-
tive overeating with an associated loss of
control. Nonovereaters reported zero for
objective overeating episodes and loss of
control questions; overeaters, $1 objec-
tive overeating episodes, but zero loss of
control episodes; subclinical binge eaters,
$1–,4 binge eating episodes; and clini-
cal binge eaters, $4b i n g ee a t i n ge p i -
sodes. Responses to each of the four
YEDEQ subscales (restraint, eating,
weight, and shape concerns) were totaled
and averaged to provide a global subscale
score, a measure of overalldistressrelated
to eating, weight, and shape concerns.
Mood was evaluated by self-report
questionnaires, the Beck Depression In-
ventory (BDI) (8), or the Child Depres-
sion Inventory (CDI) (9), depending
upon participant age. The presence of
clinically signiﬁcant mood impairment
was indicated by a BDI score $14 and
CDI $13. Quality of life (QOL) was
measured by total score on the Pediatric
Quality of Life Inventory (PedsQL) (10).
Clinically signiﬁcant impairment in
QOL was deﬁned as a total score at
least 1 SD below the mean score for the
sample.
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BRIEF REPORTRESULTS—Themeanageofthesample
was 14.0 years (41.7% Hispanic, 32.0%
black non-Hispanic, 20.1% white non-
Hispanic, 6.2% American Indian), and
64.9% were girls. Of the households,
16.9% had a primary caregiver with a
bachelor’s degree or higher educational
level, whereas more than half reported
completing high school or less. The
mean HbA1c for the sample at baseline
was 6.0 (SD = 0.7).
Fifty percent of the participants were
classiﬁed as nonovereaters, 24% as over-
eaters, 20% as subclinical binge eaters,
and6%asclinicalbingeeaters.Therewere
no signiﬁcant differences among eater cat-
egories on sex, age, race/ethnicity, house-
hold education, or on physical health
indexes such as HbA1c, blood lipids, or
b l o o dp r e s s u r e .H o w e v e r ,p a r t i c i p a n t s
classiﬁed as clinical binge eaters differed
signiﬁcantlyfromnonovereatersandover-
eaters in terms of levels and rates of obe-
sity, as measured by BMI z scores and
percentoverweight,andfromnonovereat-
ersonwaistcircumferenceandabdominal
height. Participants categorized as clinical
binge eaters had signiﬁcantly greater
global eating and weight and shape con-
cerns than nonovereaters or overeaters.
Clinical binge eaters had more depressive
symptoms than participants in any of the
other eater categories. Subclinical and
clinical binge eaters had lower QOL than
nonovereaters (see Table 1).
CONCLUSIONS—The current study
found that 26% of the youth with type 2
diabetes in this large, diverse sample
reported binge eating, with signiﬁcant
relationships between binge eating pat-
terns, higher levels of obesity, psychoso-
cial distress, and poorer QOL. The
presence of binge eating in youth with
type 2 diabetes is particularly troubling
given the association of binge eating with
accelerated weight gain in those who are
already overweight (11). The signiﬁcant
differencesinwaistcircumferenceandab-
dominal height between youth with clin-
ical levels of binge eating compared with
those without binge-eating patterns are
cause for further concern. Waist circum-
ferencehas been shown to be an indepen-
dent risk factor for cardiovascular
problems such as high blood pressure,
and visceral fat deposits have been linked
to heightened insulin resistance (12).
Because binge eating has been identi-
ﬁed as a moderator and predictor of
reduced treatment outcome in weight
loss studies (13), the results of this article
have implications for youth with type 2
diabeteswhose treatmentprescription in-
cludes disease management through
changes in eating habits and physical ac-
tivity. Furthermore, evidence from the
type 1 diabetes literature suggests that
the effects of disordered eating on clinical
outcomesarecumulative(14).Theresults
reported here highlight the importance of
early assessment for disturbed eating,
weight and shape concerns, and mood
problems, so that appropriate referral
and/or specialized treatment can be initi-
ated (15). Future research is required to
assess the impact of binge eating and its
associated features upon response to
treatment and weight reduction for youth
with type 2 diabetes.
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Table 1—Comparisons by eater category
Nonovereater Overeater
BE
P value Subclinical BE Clinical BE*
N 337 164 135 42
Mean (SD)
BMI percentile 97.5 (3.2) 97.5 (4.2) 97.9 (2.9) 98.6 (2.1) 0.1583
BMI z score 2.17 (0.46)
a 2.24 (0.50)
b 2.26 (0.45) 2.40 (0.42)
a,b 0.0077
% Overweight† 73.4 (35.8)
a,b 80.6 (37.9)
c 82.4 (37.9)
a 94.2 (36.4)
b,c 0.0012
Waist circumference (cm) 106.0 (16.5)
a,b,c 109.9 (18.0)
a 109.9 (19.2)
b 112.8 (22.4)
c 0.0171
Abdominal height (cm)†† 23.9 (3.7)
a 24.4 (4.0) 24.5 (3.7) 25.5 (3.4)
a 0.0403
Global YEDEQ 1.1 (0.9)
a,b 1.2 (0.9)
c,d 1.8 (1.0)
a,c,e 2.3 (1.0)
b,d,e ,0.0001
BDI‡ 5.1 (7.4)
a,b 5.8 (6.0)
c 8.4 (7.5)
a,d 14.5 (12.9)
b,c,d 0.0031
CDI‡ 5.6 (5.2)
a,b,c 7.5 (6.0)
a,d 8.4 (7.1)
b,e 11.1 (8.7)
c,d,e ,0.0001
PEDSQL 82.5 (11.7)
a,b,c 79.4 (11.3)
a,d 78.2 (11.5)
b,e 70.5 (12.9)
c,d,e 0.0033
Percent
Sex (% girls) 65.3 62.2 67.4 69.0 0.7488
BMI percentile $99 37.7
a,b,c 51.2
a 48.1
b,d 66.7
c,d 0.0004
Global YEDEQ $4.0 0.6
a,b 0.6
c 3.7
a 9.5
b,c ,0.0001
BDI $14 or CDI $13 10.1
a,b 16.3
c 20.3
a 30.0
b,c ,0.0001
PEDSQL ,68.2§ 11.6
a,b 17.2
c 19.1
a,d 41.5
b,c,d ,0.0001
ComparisonsacrosseatercategoriesweremadebyANOVAforcontinuousvariablesandx
2testforcategoricalvariables,followedbyunadjustedpairwisecomparisons
toexploreoverallsigniﬁcance.BE,bingeeater.*Althoughthedeﬁnitionofclinicalbingeeaterusedinthisarticleisconsistentwithproposeddeﬁnitionsofbingeeating
disorderintheDiagnosticandStatisticalManualofMentalDisorders,ﬁfthedition(DSM-V),publishedbytheAmericanPsychiatricAssociation,thecurrentstudyfocuses
on a shorter time period for diagnosis than DSM-V (1 vs. 3 months). †Percentage above age- and sex-speciﬁc median BMI. ††Also referred to as sagittal abdominal
diameter (SAD); measured laterally using a Holtain Kahn Abdominal Caliper with the patient supine. ‡BDI administered to youth age 16 years or older (N = 84 for
nonovereaters;N=44forovereaters;N=31forsubclinicalbingeeaters;N=8forclinicalbingeeaters);CDItoyouthyoungerthan16years(N=244fornormaleaters;
N=117forovereaters;N=102forsubclinicalbingeeaters;N=32forclinicalbingeeaters).§Cutoffusedis1SDbelowthesamplemean.
a,b,c,d,ePairsofvaluesinarow
with the same letters are signiﬁcantly different from each other (P , 0.05).
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